rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Patrik Jonsson

EVP & President, LLY Int'l

Company insider

Files Form 4 as: EVP & President, LLY Int'l, Eli Lilly and.

In numbers

Trades disclosed
32
Buys
0
Sells
4
Bought
$0
Sold
$18.2M
Companies
1
Companies where not an officer
0
First trade
11 Feb 2020
Last trade
17 Aug 2026
Last filed
18 Aug 2026

Companies traded

Where they are an officer
LLY Eli Lilly andOfficer · Pharmaceuticals · last 17 Aug 20260 buys · 4 sells

Activity over time

1 Dec 2024 – 1 Nov 2026
10Dec 24Jun 25Dec 25May 26Nov 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
17 Aug 2026filed 18 Aug 2026LLY Eli Lilly andPharmaceuticalsSEC FORM 4 Sold$7.6M6,500 at $1,175.10filing
17 Aug 2026filed 18 Aug 2026LLY Eli Lilly andPharmaceuticalsSEC FORM 4 Sold$7.6M6,500 at $1,175.10filing
9 Feb 2026filed 11 Feb 2026LLY Eli Lilly andPharmaceuticalsSEC FORM 4 Code A$5.0M4,818.052 at $1,044.67filing
9 Feb 2026filed 11 Feb 2026LLY Eli Lilly andPharmaceuticalsSEC FORM 4 Code A$5.0M4,818.05 at $1,044.67filing
1 Feb 2026filed 3 Feb 2026LLY Eli Lilly andPharmaceuticalsSEC FORM 4 Code M—3,930 at $0.00filing
1 Feb 2026filed 3 Feb 2026LLY Eli Lilly andPharmaceuticalsSEC FORM 4 Code F$1.8M1,752.071 at $1,037.15filing
1 Feb 2026filed 3 Feb 2026LLY Eli Lilly andoption or derivative · PharmaceuticalsSEC FORM 4 Code M—3,930 at $0.00filing
1 Feb 2026filed 3 Feb 2026LLY Eli Lilly andoption or derivative · PharmaceuticalsSEC FORM 4 Code M—3,930 at $0.00filing
1 Feb 2026filed 3 Feb 2026LLY Eli Lilly andPharmaceuticalsSEC FORM 4 Code M—3,930 at $0.00filing
1 Feb 2026filed 3 Feb 2026LLY Eli Lilly andPharmaceuticalsSEC FORM 4 Code F$1.8M1,752.07 at $1,037.15filing
10 Feb 2025filed 12 Feb 2025LLY Eli Lilly andoption or derivative · PharmaceuticalsSEC FORM 4 Code A—3,930 at $0.00filing
10 Feb 2025filed 12 Feb 2025LLY Eli Lilly andPharmaceuticalsSEC FORM 4 Code A$6.2M7,170.5 at $868.88filing
1 Feb 2025filed 4 Feb 2025LLY Eli Lilly andoption or derivative · PharmaceuticalsSEC FORM 4 Code M—3,433 at $0.00filing
1 Feb 2025filed 4 Feb 2025LLY Eli Lilly andPharmaceuticalsSEC FORM 4 Code M—3,433 at $0.00filing
1 Feb 2025filed 4 Feb 2025LLY Eli Lilly andPharmaceuticalsSEC FORM 4 Code F$1.2M1,535.86 at $811.08filing
12 Feb 2024filed 14 Feb 2024LLY Eli Lilly andoption or derivative · PharmaceuticalsSEC FORM 4 Code A—3,433 at $0.00filing
12 Feb 2024filed 14 Feb 2024LLY Eli Lilly andPharmaceuticalsSEC FORM 4 Code A$4.0M5,362 at $737.26filing
1 Feb 2024filed 2 Feb 2024LLY Eli Lilly andoption or derivative · PharmaceuticalsSEC FORM 4 Code M—4,124 at $0.00filing
1 Feb 2024filed 2 Feb 2024LLY Eli Lilly andPharmaceuticalsSEC FORM 4 Code M—4,124 at $0.00filing
1 Feb 2024filed 2 Feb 2024LLY Eli Lilly andPharmaceuticalsSEC FORM 4 Code F$1.2M1,844 at $645.61filing

Sectors

Health Care4

Buys in green, sells in red, by the company’s sector.

Related people

Anat HakimEVP, GC & Secretary · EVP, GC & Secretary at ELI LILLY & Co, filing Form 4 there in the last year
Adrienne S. BrownEVP, President LLY Imm · EVP, President LLY Imm at ELI LILLY & Co, filing Form 4 there in the last year
Kenneth L. CusterEVP & President, Card Met Hlth · EVP & President, Card Met Hlth at ELI LILLY & Co, filing Form 4 there in the last year
Eric DozierEVP, Chief People Officer · EVP, Chief People Officer at ELI LILLY & Co, filing Form 4 there in the last year
Edgardo HernandezEVP & Pres., Mfg. Operations · EVP & Pres., Mfg. Operations at ELI LILLY & Co, filing Form 4 there in the last year
Ro KhannaRepresentative, CA-17 · Also traded LLY in the last 90 days
Donald A. ZakrowskiSVP, Finance, & CAO · Also traded LLY in the last 90 days